Urothelial cancer associated 1: a long noncoding RNA with a crucial role in cancer

被引:146
|
作者
Xue, Mei [1 ]
Chen, Wei [2 ]
Li, Xu [1 ]
机构
[1] Xi An Jiao Tong Univ, Affiliated Hosp 1, Ctr Translat Med, 277 West Yanta Rd, Xian 710061, Peoples R China
[2] Xi An Jiao Tong Univ, Affiliated Hosp 1, Clin Lab, Xian 710061, Peoples R China
基金
中国国家自然科学基金;
关键词
Long noncoding RNA; UCA1; Cancer; Metastasis; Chemoresistance; CELL-CYCLE DISTRIBUTION; BLADDER-CANCER; TUMOR-SUPPRESSOR; MOLECULAR-MECHANISMS; COLORECTAL-CANCER; PROSTATE-CANCER; GASTRIC-CANCER; HEXOKINASE; UCA1; CARCINOMA;
D O I
10.1007/s00432-015-2042-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Urothelial cancer associated 1 (UCA1) is a long noncoding RNA (lncRNA) which has gained more attention in recent years due to its aberrant expression in embryogenesis and a broad range of cancer tissues and cells. Importantly, multiple studies have shown that UCA1 plays oncogenic roles in tumor growth and metastasis, and it may act as a potential biomarker and therapeutic target for human cancers. However, the molecular mechanism of UCA1 in cancer initiation, progression and metastasis remains incompletely understood. Thus, gaining a better understanding of the functional mechanism of UCA1 in cancer onset and progression is of the utmost significance for evaluating the potential application of UCA1. In this review, we discuss UCA1 expression profiling, isoform, expression regulation, biological role and mechanism for UCA1 tumor-promoting effect. We further discuss the potential clinical application of UCA1 as a promising diagnostic biomarker or therapeutic target for human cancers. UCA1 functions as an oncogenic lncRNA in several malignancies, and it might become a potential biomarker or therapeutic target for human cancers.
引用
下载
收藏
页码:1407 / 1419
页数:13
相关论文
共 50 条
  • [31] A new cancer/testis long noncoding RNA, the OTP-AS1 RNA
    Iuliia K. Karnaukhova
    Dmitrii E. Polev
    Larisa L. Krukovskaya
    Andrei A. Makashov
    Alexey E. Masharsky
    Olga V. Nazarenko
    Irina V. Poverennaya
    Vsevolod J. Makeev
    Ekaterina B. Akulova
    Andrei P. Kozlov
    Scientific Reports, 14 (1)
  • [32] Long noncoding RNA colon cancer associated transcript-1 promotes the proliferation, migration and invasion of cervical cancer
    Jia, Ligang
    Zhang, Yuan
    Tian, Fei
    Chu, Zhaoping
    Xin, Hong
    MOLECULAR MEDICINE REPORTS, 2017, 16 (04) : 5587 - 5591
  • [33] Hsa-miR-1 downregulates long non-coding RNA urothelial cancer associated 1 in bladder cancer
    Wang, Tiantian
    Yuan, Jiancheng
    Feng, Nenggui
    Li, Yuchi
    Lin, Zheguang
    Jiang, Zhimao
    Gui, Yaoting
    TUMOR BIOLOGY, 2014, 35 (10) : 10075 - 10084
  • [34] Long Noncoding RNA Signatures as Cancer Biomarkers
    Mas, Aina M.
    Huarte, Maite
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16) : 3059 - +
  • [35] Long noncoding RNA HOTAIR involvement in cancer
    Wu, Yansheng
    Zhang, Li
    Wang, Yang
    Li, Hui
    Ren, Xiubao
    Wei, Feng
    Yu, Wenwen
    Wang, Xudong
    Zhang, Lun
    Yu, Jinpu
    Hao, Xishan
    TUMOR BIOLOGY, 2014, 35 (10) : 9531 - 9538
  • [36] Long Noncoding RNA and Cancer: A New Paradigm
    Bhan, Arunoday
    Soleimani, Milad
    Mandal, Subhrangsu S.
    CANCER RESEARCH, 2017, 77 (15) : 3965 - 3981
  • [37] Targeting a Long Noncoding RNA in Breast Cancer
    Mendell, Joshua T.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (23): : 2287 - 2289
  • [38] Divergent transcription and long noncoding RNA in cancer
    Sharp, Phillip A.
    CANCER RESEARCH, 2016, 76
  • [39] Molecular Interactions of the Long Noncoding RNA NEAT1 in Cancer
    Gu, Jingtao
    Zhang, Bo
    An, Rui
    Qian, Weikun
    Han, Liang
    Duan, Wanxing
    Wang, Zheng
    Ma, Qingyong
    CANCERS, 2022, 14 (16)
  • [40] Oncogenic long noncoding RNA FAL1 in human cancer
    Zhong, Xiaomin
    Xiaowen Hu
    Zhang, Lin
    MOLECULAR & CELLULAR ONCOLOGY, 2015, 2 (02):